Lung cancer is a leading cause of death in men and women. According to World Cancer Research Fund International, lung cancer is the second most common cancer worldwide

NEW YORK, Nov. 28, 2022 (GLOBE NEWSWIRE) -- "Lung Cancer Screening Software Market" is the title of a new report from Data Bridge Market Research. Key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive environment are all dissected in detail in the research. The Lung Cancer Screening Software market report comprises of all-inclusive market data that makes it easy for the Lung Cancer Screening Software industry to take strategic decisions and attain growth objectives. This exclusive and excellent market report has been formulated by a team of keen analysts, skilled researchers, and skilled forecasters who work strictly for the best outcome. The scope of this lung cancer screening software market research report can be overviewed in terms of industry research, customer insights, market sizing and forecast, competitive analysis, market entry strategy, pricing trends, sustainability trends, innovation trends, technology evolution, and distribution channel assessment. The report assures brilliant solutions to the challenges and problems faced by the Lung Cancer Screening Software industry.

Data Bridge Market Research analyzes that the global lung cancer screening software market is expected to reach the value of USD 115,027.61 thousand by 2029, at a CAGR of 19.4% during the forecast period. Cloud based solutions accounts for largest mode of delivery segment in the market. The market report also covers pricing analysis, patent analysis and technological advancements in depth.

Gain Access to a Sample PDF of the Lung Cancer Screening Software Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lung-cancer-screening-software-market

Market Overview:

Lung cancer screening is identifying stages of lung cancer using different technologies and software. Lung cancer screening using CT is the most recommended technique for screening lung cancer. The rising use of this technique is expected to accelerate the need for advanced software for lung cancer screening. This software helps to manage patients’ participation in lung screening programs and provides an efficient way for healthcare professionals to collect, curate and transfer data to clinicians and patients. In addition, this software enables in the identification of patients at risk and automates the flow of data with integrated electronic health records.

Increase in prevalence of lung cancer, rising awareness among people about lung cancer, increasing government initiatives and growing number of screening programs are some of the major factors driving the growth of the market. In addition, advancements in Artificial Intelligence (AI)-based solutions and strategic initiatives by key market players are creating opportunities in the field of lung cancer screening software

The Global Market Is Analyzed in Depth in the Latest Study. Taking into account the current level of competition and its projected evolution over the next few years.

Rapidly increasing demands, a rise in industrialization, consumer awareness, growing sectors, and technical improvements are fueling the expansion of the global Lung Cancer Screening Software market. Sales and revenue in this sector have increased at an exponential rate. The market's size and growth are both expected to increase thanks to the factors driving the market's expansion over the projected period.

Leading businesses in the Lung Cancer Screening Software Industry are investing heavily in R&D in order to build a larger client base and expand their share of the market by reintroducing improved products to consumers. All of the companies' strategy, as well as their financial health, revenue, gross margin, and growth rate, are detailed in the study.

The Lung Cancer Screening Software Market is Dominated by Firms Such as

• PenRad Technologies Inc.,

• Koninklijke Philips N.V,

• Volpara Health Limited,

• Thynk Health,

• Nuance Communications, Inc.,

• Siemens Healthcare GmBH,

• MyCareWare, Inc.,

• MagView,

• MeVis Medical Solutions AG,

• Canon Medical Informatics, Inc.,

• General Electric Company,

• Epic Systems Corporation,

• Lungview,

• Eon,

• Medtronic,

• Coreline Soft, Co., Ltd.,

• Optellum Ltd,

• HealthMyne,

• Oncocyte Corporation,

• Genesystem,

• REVEALDX,

• FUJIFILM Holdings Corporation,

• F. Hoffmann-La Roche Ltd,

• Median Technologies,

• AstraZeneca and

• Aidence.com

Download the Complete Research Study Here in PDF Format @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-lung-cancer-screening-software-market

Recent Development

• In July 2022, GE Healthcare launched their latest product and most advanced ultrasound, the next-generation Voluson Expert 22. This latest addition to GE Healthcare’s award-winning Women’s Health portfolio utilizes graphic-based beam former technology, which produces higher quality images and offers greater flexibility in imaging functions. With this product, the company made its position much stronger in the area of products and service providers to healthcare institutions.

• In October 2021, Thynk Health announced a partnership with Infervision, to fight lung cancer with the world’s most advanced technologies. It offers an opportunity for lung cancer screening and pulmonary nodule management. With this partnership, the company increased its market presence.

Opportunities for Key Players:

• Rising collaborations, mergers & acquisitions among the market players

The companies operating in the market are adopting several strategies, including mergers and acquisitions, product launches, agreements, pipeline development, collaborations and market expansion among others, to boost their business in various dimensions. These strategic decisions by the companies are expected to offer significant opportunities for the market players operating in the market.

Key Market Segments Covered in Lung Cancer Screening Software Industry Research

Mode of Delivery

• Cloud-Based Solutions

• On-Premise Solutions

• Web Based Solutions

Product

• Lung Cancer Screening Radiology Solution

• Lung Cancer Screening Patient Management Software

• Nodule Management Software

• Data Collection and Reporting

• Patient Coordination and Workflow

• Lung Nodule Computer Aided Detection

• Pathology and Cancer Staging

• Statistical Audit Reporting

• Screening PACS

• Practice Management

• Audit Log Tracking

Type

• Computer-Assisted Screening

• Traditional Screening

Application

• Non-Small Cell Lung Cancer (NSCLC)

• Small Cell Lung Cancer (SCLC)

Platform

• Standalone

• Integrated

Purchase Mode

• Institutional

• Individual

THANKSGIVING WEEK SALE!!!

Get UP TO 35%. OFF ON GLOBAL REPORTS. OFFER VALID TILL 30th NOV 2022

For More, Inquire at https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-lung-cancer-screening-software-market

End User

• Oncology Centers

• Hospitals

• Ambulatory Surgical Centers

Distribution Channel

• Direct Tender

• Third-Party Distributors

Key Industry Drivers:

• Increase in the prevalence of lung cancer cases globally

Lung cancer is a leading cause of death in men and women. According to World Cancer Research Fund International, lung cancer is the second most common cancer worldwide. It is the most common cancer in men and second most common in women. There were more than 2.2 thousand new cases of lung cancer in 2020. Increasing prevalence of lung cancer cases creates need to adopt lung cancer screening software for early diagnosis and thus, acts as a driving factor for the market growth.

• Increase in awareness regarding the benefits of early diagnosis and frequent screening

The rising awareness programs of lung cancer by public, non-profit and private organizations are anticipated to boost the market growth. These initiatives aim to prevent diseases, reduce stigma and prejudice and promote research. The awareness among the population regarding lung cancer has increased. Because there are many awareness programs by different organizations, people know about lung cancer that can be cured if diagnosed early. Thus, raising awareness among populations is driving the market growth.

• Government initiatives were undertaken to implement screening programs for various diseases

The burden of cancer continues to increase globally and has great financial, emotional and physical stress on health systems, products, families and individuals. In countries with strong health systems, the survival rate of many types of cancer is improved due to survivorship, quality care, increased awareness and accessible early detection. Centers for Disease Control and Prevention, U.S., tribes and the U.S.-Pacific islands and territories through the National Comprehensive Cancer Control Program (NCCCP) are to form or support alliances to combat cancer in their communities. Due to these initiatives, more audiences are educated and more consciously dispersed, pushing the global audience to take further precautions and practice preventive examinations, promoting the market.

• Growing number of screening programs across the globe

Screening is an effective method of detecting early-stage cancer. There is an increasing trend in lung cancer incidences in developing countries. Although there are regular recommendations for screening for breast and cervical cancer, it is not the same in case of lung cancer. Most countries or institutions have initiated the feasibility and disease screening of Low-Dose Computed Tomography (LDCT) for lung cancer. The increasing number of lung cancer screening has created an opportunity for the market players. Hence, the increasing diagnostic rate acts as a driving factor for market growth.

Browse a Detailed Summary of the Research Report @ https://www.databridgemarketresearch.com/reports/global-lung-cancer-screening-software-market

Lung Cancer Screening Software Market Regional Analysis/Insights:

The countries covered in this Lung Cancer Screening Software Market Report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, U.A.E., Saudi Arabia, Israel, Egypt, South Africa, and rest of Middle East and Africa.
North America region is expected to dominate the market and is the fastest-growing region owing to the factors such as increasing number of screening programs, growing adoption of software solutions for patient management, rise in the demand for screening with chest radiography and the presence of large number of screening centers.

It's in your best interest to take this report into consideration because:

• Strong and extensive research methods were used to construct this study. The thoroughness and precision of the market reports produced by Data Bridge Market Research have earned them a great reputation.

• A complete picture of the competitive scenario of Lung Cancer Screening Software market is depicted by this report.

• The wide range of research on how these innovations may affect market expansion in the future.

• The report's findings are presented in an approachable format, with accompanying visuals (such as histograms, bar graphs, pie charts, etc.) that make the data readily digestible.

• The potential, threats, and difficulties in the Lung Cancer Screening Software market, as well as the factors driving and restraining it, are discussed at length.

• It gives an all-encompassing evaluation of the anticipated conduct of the future market and the changing market condition.

• This study provides a number of strategic business approaches to assist you in making educated business decisions.

Table of Contents:

1. Introduction
2. Market Segmentation
3. Executive Summary
4. Premium Insights
5. Global Lung Cancer Screening Software Market: Regulations
6. Market Overview
7. Global Lung Cancer Screening Software Market, By Mode of Delivery
8. Global Lung Cancer Screening Software Market, By Product
9. Global Lung Cancer Screening Software Market, By Type
10. Global Lung Cancer Screening Software Market, By Application
11. Global Lung Cancer Screening Software Market, By Platform
12. Global Lung Cancer Screening Software Market, By Purchase Mode
13. Global Lung Cancer Screening Software Market, By End User
14. Global Lung Cancer Screening Software Market, By Distribution Channel
15. Global Lung Cancer Screening Software Market, By Region
16. Global Lung Cancer Screening Software Market: Company Landscape
17. SWOT Analyses
18. Company Profile
19. Questionnaires
20. Related Reports

Get the Full Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-lung-cancer-screening-software-market

Explore More Reports:

• Middle East and Africa Lung Cancer Screening Software Market, By Mode of Delivery (Cloud Based Solutions, On-Premise Solutions and Web Based Solutions), Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACs, Practice Management and Audit Log Tracking), Type (Computer-Assisted Screening and Traditional Screening), Application (Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)), Platform (Standalone and Integrated), Purchase Mode (Institutional and Individual), End User (Oncology Centers, Hospitals, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender and Third Party Distributors) https://www.databridgemarketresearch.com/reports/middle-east-and-africa-lung-cancer-screening-software-market

• Asia-Pacific Lung Cancer Screening Software Market, By Mode of Delivery (Cloud Based Solutions, On-Premise Solutions and Web Based Solutions), Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACs, Practice Management and Audit Log Tracking), Type (Computer-Assisted Screening and Traditional Screening), Application (Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)), Platform (Standalone and Integrated), Purchase Mode (Institutional and Individual), End User (Oncology Centers, Hospitals, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender and Third Party Distributors) https://www.databridgemarketresearch.com/reports/asia-pacific-lung-cancer-screening-software-market

• Europe Lung Cancer Screening Software Market, By Mode of Delivery (Cloud Based Solutions, On-Premise Solutions and Web Based Solutions), Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACs, Practice Management and Audit Log Tracking), Type (Computer-Assisted Screening and Traditional Screening), Application (Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)), Platform (Standalone and Integrated), Purchase Mode (Institutional and Individual), End User (Oncology Centers, Hospitals, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender and Third Party Distributors) https://www.databridgemarketresearch.com/reports/europe-lung-cancer-screening-software-market

• North America Lung Cancer Screening Software Market, By Mode of Delivery (Cloud Based Solutions, On-Premise Solutions and Web Based Solutions), Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACs, Practice Management and Audit Log Tracking), Type (Computer-Assisted Screening and Traditional Screening), Application (Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)), Platform (Standalone and Integrated), Purchase Mode (Institutional and Individual), End User (Oncology Centers, Hospitals, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender and Third Party Distributors) https://www.databridgemarketresearch.com/reports/north-america-lung-cancer-screening-software-market

• U.S. Lung Cancer Screening Software Market, By Mode of Delivery (Cloud Based Solutions, On-premise Solutions, & Web Based Solutions), Type (Computer-Assisted Screening and Traditional Screening), Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACs, Practice Management & Audit Log Tracking), Application (Non-Small Cell Lung Cancer (NSCLC) & Small Cell Lung Cancer (SCLC), Platform (Standalone, Integrated), Purchase Mode (Institutional & Individual), End User (Oncology Centers, Hospitals, Ambulatory Surgical Centers & Others), Distribution Channel (Direct Tenders, Third Party Distributor) https://www.databridgemarketresearch.com/reports/us-lung-cancer-screening-software-market

• Lung Cancer Surgery Market, By Product Type (Surgical Instruments, Monitoring & Visualizing System, Endosurgical Equipment, Robotic-Assisted Thoracic Surgery Systems And Others), Surgical Procedure (Thoracotomy And Minimally Invasive Surgery), Patient Type (Male And Female), End User (Hospitals, Ambulatory Surgical Centres, Academic & Research Laboratories, Speciality Cancer Care Centres And Others), Distribution Channel (Direct Tender, Retail Sales, Online Sales and Others) https://www.databridgemarketresearch.com/reports/global-lung-cancer-surgery-market

• Lung Cancer Therapeutics Market, By Cancer Type (Non-Small Cell Lung Cancer, Metastatic Lung Cancer, Pulmonary Neuroendocrine Tumours, Mediastinal Tumours, Mesothelioma, Chest Wall Tumours), Molecule Type (Small Molecules and Biologics), Drug Class (Alkylating Agents, Antimetabolites, EGFR Inhibitors, Mitotic Inhibitors, Multikinase Inhibitors and Others), Treatment Type (Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy and Others), Therapy Type (Single Drug Therapy and Combination Therapy), End User (Hospitals, Homecare, Speciality Clinics and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online and Others) https://www.databridgemarketresearch.com/reports/global-lung-cancer-therapeutics-market

• Middle East and Africa Lung Cancer Therapeutics Market, By Cancer Type (Non-Small Cell Lung Cancer, Metastatic Lung Cancer, Pulmonary Neuroendocrine Tumours, Mediastinal Tumours, Mesothelioma, Chest Wall Tumours), Molecule Type (Small Molecules and Biologics), Drug Class (Alkylating Agents, Antimetabolites, EGFR Inhibitors, Mitotic Inhibitors, Multikinase Inhibitors and Others), Treatment Type (Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy and Others), Therapy Type (Single Drug Therapy and Combination Therapy), End User (Hospitals, Homecare, Speciality Clinics and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online and Others), Country (South Africa, Saudi Arabia, UAE, Egypt, Israel and Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/middle-east-and-africa-lung-cancer-therapeutics-market

• North America Lung Cancer Therapeutics Market, By Cancer Type (Non-Small Cell Lung Cancer, Metastatic Lung Cancer, Pulmonary Neuroendocrine Tumours, Mediastinal Tumours, Mesothelioma, Chest Wall Tumours), Molecule Type (Small Molecules and Biologics), Drug Class (Alkylating Agents, Antimetabolites, EGFR Inhibitors, Mitotic Inhibitors, Multikinase Inhibitors and Others), Treatment Type (Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy and Others), Therapy Type (Single Drug Therapy and Combination Therapy), End User (Hospitals, Homecare, Speciality Clinics and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online and Others), Country (U.S., Canada and Mexico) https://www.databridgemarketresearch.com/reports/north-america-lung-cancer-therapeutics-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.